Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial

Sandra P D'Angelo, Dejka M Araujo, Albiruni R Abdul Razak, Mark Agulnik, Steven Attia, Jean-Yves Blay, Irene Carrasco Garcia, John A Charlson, Edwin Choy, George D Demetri, Mihaela Druta, Edouard Forcade, Kristen N Ganjoo, John Glod, Vicki L Keedy, Axel Le Cesne, David A Liebner, Victor Moreno, Seth M Pollack, Scott M Schuetze, Gary K Schwartz, Sandra J Strauss, William D Tap, Fiona Thistlethwaite, Claudia Maria Valverde Morales, Michael J Wagner, Breelyn A Wilky, Cheryl McAlpine, Laura Hudson, Jean-Marc Navenot, Tianjiao Wang, Jane Bai, Stavros Rafail, Ruoxi Wang, Amy Sun, Lilliam Fernandes, Erin Van Winkle, Erica Elefant, Colin Lunt, Elliot Norry, Dennis Williams, Swethajit Biswas, Brian A Van Tine

Open source

DOI: 10.1016/s0140-6736(24)00319-2
Published: 2024-04
Container: The Lancet
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/s0140-6736-24-00319-2,
  title = {Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial},
  author = {Sandra P D'Angelo and Dejka M Araujo and Albiruni R Abdul Razak and Mark Agulnik and Steven Attia and Jean-Yves Blay and Irene Carrasco Garcia and John A Charlson and Edwin Choy and George D Demetri and Mihaela Druta and Edouard Forcade and Kristen N Ganjoo and John Glod and Vicki L Keedy and Axel Le Cesne and David A Liebner and Victor Moreno and Seth M Pollack and Scott M Schuetze and Gary K Schwartz and Sandra J Strauss and William D Tap and Fiona Thistlethwaite and Claudia Maria Valverde Morales and Michael J Wagner and Breelyn A Wilky and Cheryl McAlpine and Laura Hudson and Jean-Marc Navenot and Tianjiao Wang and Jane Bai and Stavros Rafail and Ruoxi Wang and Amy Sun and Lilliam Fernandes and Erin Van Winkle and Erica Elefant and Colin Lunt and Elliot Norry and Dennis Williams and Swethajit Biswas and Brian A Van Tine},
  year = {2024},
  journal = {The Lancet},
  doi = {10.1016/s0140-6736(24)00319-2},
  url = {https://doi.org/10.1016/s0140-6736(24)00319-2}
}

RIS

TY  - JOUR
TI  - Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial
AU  - Sandra P D'Angelo
AU  - Dejka M Araujo
AU  - Albiruni R Abdul Razak
AU  - Mark Agulnik
AU  - Steven Attia
AU  - Jean-Yves Blay
AU  - Irene Carrasco Garcia
AU  - John A Charlson
AU  - Edwin Choy
AU  - George D Demetri
AU  - Mihaela Druta
AU  - Edouard Forcade
AU  - Kristen N Ganjoo
AU  - John Glod
AU  - Vicki L Keedy
AU  - Axel Le Cesne
AU  - David A Liebner
AU  - Victor Moreno
AU  - Seth M Pollack
AU  - Scott M Schuetze
AU  - Gary K Schwartz
AU  - Sandra J Strauss
AU  - William D Tap
AU  - Fiona Thistlethwaite
AU  - Claudia Maria Valverde Morales
AU  - Michael J Wagner
AU  - Breelyn A Wilky
AU  - Cheryl McAlpine
AU  - Laura Hudson
AU  - Jean-Marc Navenot
AU  - Tianjiao Wang
AU  - Jane Bai
AU  - Stavros Rafail
AU  - Ruoxi Wang
AU  - Amy Sun
AU  - Lilliam Fernandes
AU  - Erin Van Winkle
AU  - Erica Elefant
AU  - Colin Lunt
AU  - Elliot Norry
AU  - Dennis Williams
AU  - Swethajit Biswas
AU  - Brian A Van Tine
PY  - 2024
JO  - The Lancet
DO  - 10.1016/s0140-6736(24)00319-2
UR  - https://doi.org/10.1016/s0140-6736(24)00319-2
ER  -

APA

D'Angelo, S. P., Araujo, D. M., Razak, A. R. A., Agulnik, M., Attia, S., Blay, J., Garcia, I. C., Charlson, J. A., Choy, E., Demetri, G. D., Druta, M., Forcade, E., Ganjoo, K. N., Glod, J., Keedy, V. L., Cesne, A. L., Liebner, D. A., Moreno, V., Pollack, S. M., Schuetze, S. M., Schwartz, G. K., Strauss, S. J., Tap, W. D., Thistlethwaite, F., Morales, C. M. V., Wagner, M. J., Wilky, B. A., McAlpine, C., Hudson, L., Navenot, J., Wang, T., Bai, J., Rafail, S., Wang, R., Sun, A., Fernandes, L., Winkle, E. V., Elefant, E., Lunt, C., Norry, E., Williams, D., Biswas, S., & Tine, B. A. V. (2024). Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trial. The Lancet. https://doi.org/10.1016/s0140-6736(24)00319-2

Source records

crossref · retrieved 2026-09-27T13:10:56.877Z